2,000
Participants
Start Date
September 28, 2018
Primary Completion Date
February 20, 2025
Study Completion Date
February 20, 2025
EmboTrap® Revascularization Device
EmboTrap® Revascularization Device
CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter
CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter
CEREGLIDE 71 Intermediate Catheter
CEREGLIDE 71 Intermediate Catheter
Kantonsspital Aarau, Aarau
Az Groeninge, Kortrijk
Icahn School of Medicine at Mount Sinai, New York
Jacobs Institute/UB Neurosurgery, Inc., Buffalo
Geisinger Clinic, Danville
Geisinger, Danville
Thomas Jefferson University, Philadelphia
Universitaetsklinikum Hamburg Eppendorf, Hamburg
WellStar Health System, Marietta
Emory School of Medicine at Grady Memorial Hospital, Atlanta
University of Massachusetts, Worcester
Baptist Medical Center, Jacksonville
Lyerly Neurosurgery Baptist Health, Jacksonville
Advent Health Orlando, Orlando
Memorial Regional Hospital, Hollywood
University of Miami- Jackson Memorial Hospital, Miami
The University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
TNVI, Knoxville
University of Tennessee Medical Center, Knoxville
Semmes Murphey Foundation, Memphis
Norton Healthcare, Louisville
Radprax MVZ Nordrhein GmbH, Solingen
Norton Neurology Institute, Elizabethtown
Ohio Health, Columbus
Mercy Health St Vincent Medical Center, Toledo
Klinikum Dortmund gGmbH, Dortmund
Cleveland Clinic, Cleveland
Universitaetsmedizin Mainz, Mainz
Hopital Roger Salengro - CHU Lille, Lille
Washington University in St. Louis, St Louis
Texas Stroke Institute, Plano
University of Texas Houston, Houston
Barrow Neurological Institute at St. Joseph's Hospital, Phoenix
Banner Desert Medical Center, Mesa
Hadassah Medical Center, Jerusalem
Vascular Neurology of Southern California: Dr. M. Asif Taqi, Thousand Oaks
Oregon Health & Science University, Portland
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Charing Cross Hospital, London
Cerenovus, Part of DePuy Synthes Products, Inc.
INDUSTRY